Zobrazeno 1 - 10
of 55
pro vyhledávání: '"S. Craig Risch"'
Autor:
Jeffrey L Waugh, Jeremy Celver, Meenakshi Sharma, Robert L Dufresne, Dimitra Terzi, S Craig Risch, William G Fairbrother, Rachael L Neve, John P Kane, Mary J Malloy, Clive R Pullinger, Harvest F Gu, Christos Tsatsanis, Steven P Hamilton, Stephen J Gold, Venetia Zachariou, Abraham Kovoor
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e27984 (2011)
Regulator of G protein signaling 9-2 (RGS9-2) is a protein that is highly enriched in the striatum, a brain region that mediates motivation, movement and reward responses. We identified a naturally occurring 5 nucleotide deletion polymorphism in the
Externí odkaz:
https://doaj.org/article/540498c151d14f688ea36e5e43397dd0
Seasonal variations in neurotransmitter parameters have been previously reported in humans. However, these studies have involved small sample sizes and have not examined possible relationships with meteorological variables. We compared cerebrospinal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc28763891aa92f6687f24a7bc1a4765
https://europepmc.org/articles/PMC5849528/
https://europepmc.org/articles/PMC5849528/
Autor:
Susan R. McGurk, Simmy Palecko, C. Lindsay DeVane, Ziad Nahas, S. Craig Risch, John S. Markowitz, Michael David Horner
Publikováno v:
Schizophrenia Research. 93:131-135
Thirteen outpatients with chronic but stable schizophrenia received donepezil and placebo augmentation of their maintenance antipsychotic medication regimen. Each subject received in a randomized, counterbalanced order 1) donepezil 5 mg for 6 weeks t
Autor:
Kenneth T. Cheng, John S. Markowitz, Heidi L. Liston, C. Lindsay DeVane, S. Craig Risch, Jennifer L. Donovan, Lauren Willard
Publikováno v:
Journal of Clinical Psychopharmacology. 24:4-10
An antidepressant for use in the patient receiving concomitant drug treatment, over-the-counter medications, or herbal products should lack cytochrome P-450 (CYP) 3A4 inductive or inhibitory activity to provide the least likelihood of a drug-drug int
Autor:
Christopher Liberatos, Ziad Nahas, Jeffrey P. Lorberbaum, M. Molloy, Cart DeBrux, Veena Chandler, S. Craig Risch, Andrew M. Speer, Mark S. George
Publikováno v:
The Journal of ECT. 16:380-390
Repetitive transcranial magnetic stimulation (rTMS) is a new technology for exploring brain function. With this method, a small electromagnet is placed on the scalp; by activating and deactivating it, nerve cells in the underlying superficial cortex
Autor:
Nicholas C. Oliver, M. Molloy, Patrick L Hughes, Mark S. George, S. Craig Risch, George W. Arana, Ziad Nahas
Publikováno v:
Bipolar Disorders. 1:73-80
Objectives Transcranial magnetic stimulation (TMS) affects the brain by non-invasively stimulating the cerebral cortex and inducing electrical currents in neurons. The powerful magnetic field acts as a vector that passes across the scalp and the skul
Autor:
Charlotte C. Teneback, M. Molloy, Kenneth T. Cheng, Laurie E. Stallings, S. Craig Risch, Diana J. Vincent, Andrew M. Speer, Kenneth M. Spicer, Mark S. George, Daryl E. Bohning, Ziad Nahas
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 14:161-170
Although transcranial magnetic stimulation has been used as a stand-alone brain mapping tool, relatively few studies have attempted to couple TMS with functional brain imaging to understand the neurobiological effects of TMS. Technical problems of pl
Autor:
S. Craig Risch, George W. Arana, Charlotte C. Teneback, M. Molloy, Andrew M. Speer, Robert M. Post, James C. Ballenger, Ziad Nahas, Mark S. George
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 13:271-275
Preliminary studies in unipolar depression indicate that daily left prefrontal repetitive transcranial magnetic stimulation (rTMS) reduces symptoms of depression. rTMS treatment of depression occurring in the setting of bipolar disorder has been less
Autor:
Laurie E. Stallings, Wendol A. William, S. Craig Risch, Timothy A. Kimbrell, Eric M. Wassermann, Robert M. Post, Mark S. George, Andrew M. Speer, Charles H. Kellner
Publikováno v:
CNS Spectrums. 2:39-44
Recent advances in functional neuroimaging (including positron emission tomography, single-photon emission tomography, and fast magnetic resonance imaging) have allowed better understanding of the brain regions involved in regulating normal and patho
Publikováno v:
The Journal of Clinical Pharmacology. 42:104-106
Olanzapine is an atypical antipsychotic medication indicated for the treatment of schizophrenia and other manifestations of psychotic illness. Common side effects include somnolence, constipation, weight gain, and postural hypotension. The authors re